Sex test for women in elite sports takes toll on right to equality, privacy
Last week, the International Olympic Committee (IOC) banned transgender women and athletes with differences in sex development, with some exceptions, from competing in the women’s categories for elite sporting events such as Olympic Games. The decision is apparently based on apprehensions about the unfair advantages these athletes may enjoy due to biological reasons. The IOC also mandated a once-in-a-lifetime SRY test or sex test for women athletes. Until now, the Committee had left the matter to international federations. The new policy, the latest in a series of bans and rollbacks, is ostensibly to ensure standardisation — since the “smallest margins” can change outcomes in elite sports. With the 2028 Los Angeles Olympics coming up, it may also have been motivated by a desire to avoid conflict with the Donald Trump administration, which has banned trans women from women’s sports.
Questions of accuracy and reliability surround the Sex-determining Region Y (SRY) test. Biological sex is determined by an interplay of chromosomal, gonadal, hormonal, and phenotypic factors. Only testing positive for the SRY gene does not mean that an athlete benefits from the hormone it produces. There is also no conclusive evidence that transgender women hold an athletic advantage over cisgender women. In fact, after the 1996 Olympics, the IOC had started phasing out universal sex testing, stating that it was an inaccurate metric to determine sex and athletic advantage, besides being unethical. Sex testing also disproportionately impacts women from the Global South and women of colour. Their genetic makeup diverges from the Eurocentric standards used for most testing and eligibility criteria.
The ban, alongside mandatory medical testing for women, undermines principles of equality—male athletes do not have to cross the medical test hurdle. It raises the entry barrier for athletes, especially from low-resource backgrounds, and violates women’s dignity and privacy. It also diverts attention from the many real obstacles women athletes face: Unequal funding, lack of access to training, pay disparity, gender-based violence, besides stigmatising transgender and DSD athletes. A policy intended to ensure fairness for women in sports needs to be grounded in scientific evidence. It cannot come at the cost of basic rights, and by making conditions for participation tougher for those it claims to protect.
- 1The International Olympic Committee's (IOC) mandatory SRY test for women athletes raises significant constitutional concerns regarding the right to equality and privacy. Such a policy, not applied to male athletes, constitutes discrimination and violates bodily autonomy. It undermines the dignity of women athletes, especially those from the Global South, by imposing Eurocentric testing standards, potentially infringing upon fundamental rights akin to those protected under Article 21 of the Indian Constitution.
- 2The International Olympic Committee's (IOC) decision to ban transgender women and mandate SRY tests exemplifies how international sporting governance can be influenced by political pressures, such as avoiding conflict with the US administration. This highlights the complex interplay between global sports bodies and national governments, where policy decisions, ostensibly for "standardisation," can override principles of fair governance and inclusion, impacting athletes globally.
- 3The IOC's new policy, including mandatory medical testing, creates significant economic and social barriers, particularly for athletes from low-resource backgrounds. It diverts focus from systemic issues like unequal funding, lack of training access, and gender-based violence, while simultaneously stigmatising transgender and DSD athletes. This approach exacerbates existing inequalities and undermines efforts towards genuine inclusion and support for all women in sports.
- 4The IOC's reliance on the SRY test for determining eligibility is scientifically questionable, as biological sex involves complex chromosomal, gonadal, and hormonal factors beyond a single gene. There is no conclusive scientific evidence proving a consistent athletic advantage for transgender women over cisgender women. This policy disregards prior IOC acknowledgements of testing inaccuracies, highlighting a concerning disconnect between scientific understanding and policy formulation in elite sports.